MRS Awards And Recognitions
The MRS recognizes excellence in the field of metastasis by awarding the Paget-Ewing Award. The Paget-Ewing Award is named after Sir Stephen Paget and Dr. James Ewing, pioneers in metastasis research in the late 19th and early 20th centuries who proposed the two major theories to explain organ selectivity of metastasis.
The Paget-Ewing Award is the highest honor bestowed by the Metastasis Research Society and honors a person's scientific excellence and substantial contributions to the understanding and/or control of cancer metastasis. Service to the MRS, or to the field in general, is not a primary criterion for the award. The award is open to all members of the metastasis research community apart from current members of the Board of Directors of the Metastasis Research Society and will be offered biennially.
|Paget-Ewing Award Recipients|
Fidler Innovation Award
The I.J. "Josh" Fidler Innovation in Metastasis Research Award acknowledges the special contributions of Dr. Fidler, who developed new models, shifted the manner in which metastasis is studied in experimental settings, contributed to our fundamental understanding of tumor progression and heterogeneity and continues to be instrumental in translating laboratory findings into the clinical management of metastatic disease. The award is given to an investigator who has made innovative contributions to metastasis research, thereby influencing the direction -- either technically or conceptually -- of this area of research. The award, sponsored by Anti-Cancer Inc. is open to all members of the research community apart from current members of the Board of Directors of the Metastasis Research Society.
|Fidler innovation Award Recipients|
The Kurt Hellman Award for the translation of metastasis research into clinical practice.
The renowned clinical pharmacologist Kurt Hellmann (1922-2013) was one of the founding fathers of the Metastasis Research Society and an early pioneer in the translation of basic metastasis research findings into clinical application. The Kurt Hellmann Award Lecture honors his outstanding contribution to the field. The award is given to an investigator who has contributed significantly to the translation of metastasis research into clinical practice. The award, sponsored by Novartis, is open to all members of the research community apart from current members of the Board of Directors of the Metastasis Research Society.
Winner 2014: Sue Eccles (Click HERE for more information about the Kurt Hellman Award and Dr. Eccles contribution.
The Sue Eccles Young Investigator Award in Cancer Metastasis Research.
The MRS board of directors recently agreed to establish a Young Investigator Award in honor of Dr. Sue Eccles, one of our most accomplished investigators an original supporter of the MRS. With this award the MRS honors excellent metastasis research performed by members of the MRS who are 40 years old or less. The inaugural award will be given at the MRS biennial conference in 2016 to an early-stage team leader who has established his/her own research group. Eligible work for consideration should have been carried out after postdoctoral training and before tenure. Self-nomination is possible. Current members of the MRS board are not eligible. Nominations should include a brief outline of work performed after postdoctoral training, a CV that includes a publication list in which papers published after postdoctoral training are highlighted, and the Pubmed ID of the three most important papers published as an early-stage team leader.
In addition to a monetary prize, the award includes financing for the recipient to attend and talk at the MRS biennial conference that will be held in Chengdu, China in September 2016.
Nominations should be submitted by 31st December 2015 to firstname.lastname@example.org